Journal article
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
- Abstract:
-
Background
Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID therapy in a European setting.
Method
Patients aged 60 years and over with osteoarthritis or rheumatoid arthritis, free from established CV disease and taking chronic prescribed nsNSAIDs, were randomiz...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 388.6KB, Terms of use)
-
- Publisher copy:
- 10.1093/eurheartj/ehw387
Authors
Funding
Bibliographic Details
- Publisher:
- Oxford University Press
- Journal:
- European Heart Journal More from this journal
- Volume:
- 38
- Issue:
- 23
- Pages:
- 1843-1850
- Publication date:
- 2016-10-01
- Acceptance date:
- 2016-08-10
- DOI:
- EISSN:
-
1522-9645
- ISSN:
-
0195-668X
- Pmid:
-
27705888
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:650656
- UUID:
-
uuid:af570b27-6c82-43a9-b355-919b572066d9
- Local pid:
-
pubs:650656
- Source identifiers:
-
650656
- Deposit date:
-
2018-02-27
Terms of use
- Copyright holder:
- Hobbs et al
- Copyright date:
- 2016
- Notes:
- © The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record